CABIRALIZUMAB: 61 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
61
Total FAERS Reports
16 (26.2%)
Deaths Reported
54
Hospitalizations
61
As Primary/Secondary Suspect
13
Life-Threatening
3
Disabilities
First Report: 20161028 · Latest Report: 20210430
What Are the Most Common CABIRALIZUMAB Side Effects?
#1 Most Reported
Sepsis
5 reports (8.2%)
#2 Most Reported
Malignant neoplasm progression
5 reports (8.2%)
#3 Most Reported
Pneumonia
4 reports (6.6%)
All CABIRALIZUMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 5 | 8.2% | 5 | 5 |
| Sepsis | 5 | 8.2% | 5 | 5 |
Who Reports CABIRALIZUMAB Side Effects? Age & Gender Data
Gender: 46.9% female, 53.1% male. Average age: 63.0 years. Most reports from: US. View detailed demographics →
Is CABIRALIZUMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 5 | 1 | 5 |
| 2017 | 22 | 5 | 19 |
| 2018 | 12 | 3 | 12 |
| 2019 | 17 | 6 | 16 |
| 2020 | 1 | 0 | 0 |
| 2021 | 2 | 0 | 2 |
What Is CABIRALIZUMAB Used For?
| Indication | Reports |
|---|---|
| Pancreatic carcinoma | 24 |
| Neoplasm malignant | 18 |
Official FDA Label for CABIRALIZUMAB
Official prescribing information from the FDA-approved drug label.